Alkermes to Present Data From Late-Stage CNS Portfolio at Upcoming American Society of Clinical Psychopharmacology Annual Meeting
June 16, 2015 at 07:01 AM EDT
Alkermes plc (NASDAQ: ALKS) today announced that data from studies of the company's pipeline of central nervous system (CNS) drug ...
